These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: CA-125. Use as a tumor marker with mixed mesodermal tumors of the female genital tract.
    Author: Peters WA, Bagley CM, Smith MR.
    Journal: Cancer; 1986 Dec 15; 58(12):2625-7. PubMed ID: 3022909.
    Abstract:
    CA-125 levels were determined in seven patients with a mixed mesodermal tumor of the ovary or endometrium. An elevated level was detected in five of six patients with metastatic or recurrent disease. Chemotherapy with cisplatin and Adriamycin (doxorubicin) resulted in a response in four patients, and the CA-125 level correlated well with the clinical status of the disease. Cisplatin/Adriamycin is an active combination in mixed mesodermal tumors and CA-125 appears to be a useful marker for following therapy.
    [Abstract] [Full Text] [Related] [New Search]